Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma

Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma

Abstract Backgroud Establishing diagnostic and prognostic biomarkers of primary central nervous system lymphoma (PCNSL) is a challenge. This study evaluated the value of dynamic interleukin (IL)-10 cerebrospinal fluid (CSF) concentrations for prognosis and relapse prediction in PCNSL. Methods Consec...

Full description

Bibliographic Details
Main Authors: Yan Zhang, Dongmei Zou, Jingjing Yin, Li Zhang, Xiao Zhang, Wei Wang, Meifen Zhang, Daobin Zhou, Wei Zhang
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Cancer
Subjects:
Primary central nerves system lymphoma
Cerebrospinal fluid
Interleukin-10
Monitoring
Relapse
Online Access:https://doi.org/10.1186/s12885-020-07774-5

Internet

https://doi.org/10.1186/s12885-020-07774-5

Similar Items